Identification of some variable parameters in serum of COVID-19 patients in comparison with control group

The Egyptian Journal of Immunology
Volume 31 (2), April, 2024
Pages: 10 – 17.
www.Ejimmunology.org
https://doi.org/10.55133/eji.310202
Ebtihal C. Abbas1, Mais M. Salim1, Ahmed C. Abbas2, and Ahmed Z. Alwaeli3
1Department of Pathology & Forensic Medicine, Faculty of Medicine University of Kufa, Kufa, Iraq.

2Department of Health & Exercise, Kristiania University Oslo, Norway.

3Department of Microbiology, Faculty of Medicine University of Alameed, Karbala, Iraq.

Corresponding author:
Mais M. Salim, Department of Pathology & Forensic Medicine, Faculty of Medicine University of Kufa, Kufa, P.O., Box 21, Najaf Governorate, Iraq.
Email: maysm.mhasan@uokufa.edu.iq

 

Abstract

The study intended to determine the correlation among coronavirus disease 2019 (COVID-19) infection and variable abnormalities in liver function test, lipids, and thyroid hormones. The study included 160 infected COVID-19 patients (80 females and 80 male) and 100 subjects as a control group (50 females and 50 males), attended the Al-Sader Medical City in Al-Najaf, Iraq during the period between January 2021 to October 2021. The patients’ age ranged from 16-80 years old. Liver enzymes, lipid profile and thyroid hormone were tested. The results revealed a significant increase in liver function levels including alanine transaminase, aspartate aminotransferase, alkaline phosphatase, and Albumin (p<0.05). Also, there was an increase in lipids levels including total cholesterol, low-density lipoprotein, and triglycerides. The result showed significant difference in levels of thyroid hormones triiodothyronine, thyroxine and thyroid stimulating hormone between COVID-19 infected patients and the control group. As well the antithyroid antibodies (thyroglobulin antibody, thyroid peroxidase antibody and thyrotropin receptor antibodies) were increased. There was a correlation between increasing thyroid hormones and their antibodies with infection by COVID-19. This study concluded that COVID-19 infection can induce disturbances in liver and thyroid function tests and changes in the lipid metabolism.

Keywords:
COVID 19; lipid profile; Thyroid hormones; Liver function tests; Thyroid antibody.

Date received: 02 July 2023; accepted: 06 January 2024

PMID:
38615200

 

Full Text